✦ LIBER ✦

Prognostic Evaluation of CapG, Gelsolin, P-gp, GSTP1, and Topo-II Proteins in Non-Small Cell Lung Cancer

✍ Scribed by Wang-Yu Zhu; Yan-Yan Hunag; Xiao-Guang Liu; Jian-Ying He; Dong-Dong Chen; Fang Zeng; Ji-Hang Zhou; Yong-Kui Zhang

Publisher: Wiley (John Wiley & Sons)
Year: 2011
Tongue: English
Weight: 329 KB
Volume: 295
Category: Article
ISSN: 1932-8486
DOI: 10.1002/ar.21523

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantitative analysis of p53 protein in

Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value

✍ Michael A. Levesque; Mario D'Costa; Ernest H. Spratt; Mohammad M. Yaman; Elefthe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views